Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by mutations in the survival motor neuron 1 (<i>SMN2</i>) gene. All patients have at least one copy of a paralog, <i>SMN2</i>, but a C-to-T transition in this gene results in exon 7 skipping in a majority of tra...
Váldodahkkit: | Winkelsas, AM, Grunseich, C, Harmison, GG, Chwalenia, K, Rinaldi, C, Hammond, SM, Johnson, K, Bowerman, M, Arya, S, Talbot, K, Wood, MJ, Fischbeck, KH |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
Cell Press
2021
|
Geahča maid
-
Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Dahkki: Audrey M. Winkelsas, et al.
Almmustuhtton: (2021-03-01) -
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Dahkki: Winkelsas, AM
Almmustuhtton: (2020) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Dahkki: Bowerman, M, et al.
Almmustuhtton: (2017) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Dahkki: Bowerman, M, et al.
Almmustuhtton: (2017) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Dahkki: Melissa Bowerman, et al.
Almmustuhtton: (2017-08-01)